Many papers have addressed the association of elevated plasma IL-18 level with mortality in ARDS (Makabe et al., 2012; Dong et al., 2019; Rogers et al., 2019), emphasizing the connection between NLRP3 inflammasome and COVID-19 progression. This evidence concerns the gene IL18 and COVID-19.